Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk.

@article{NelsonPiercy1997LowmolecularweightHF,
  title={Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk.},
  author={Catherine Nelson-Piercy and Elizabeth A Letsky and Michael de Swiet},
  journal={American journal of obstetrics and gynecology},
  year={1997},
  volume={176 5},
  pages={1062-8}
}
OBJECTIVE Our purpose was to investigate the use of low-molecular-weight heparin (enoxaparin, Clexane) for thromboprophylaxis in pregnancy. STUDY DESIGN A prospective consecutive cohort of 61 pregnant women at high risk of thromboembolism receiving antenatal thromboprophylaxis with enoxaparin (usually 40 mg, subcutaneously daily) in a total of 69 pregnancies was identified from the obstetric medicine clinic at Queen Charlotte's Hospital. Bone density measurements of the hip and lumbar spine… CONTINUE READING